Kayne Anderson Rudnick Investment Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-974,434
Closed -$10.1M 886
2023
Q1
$10.1M Buy
974,434
+10,861
+1% +$128K 0.03% 249
2022
Q4
$10.6M Sell
963,573
-85,235
-8% -$1.1M 0.03% 253
2022
Q3
$16.3M Sell
1,048,808
-67,061
-6% -$1.47M 0.05% 203
2022
Q2
$25.6M Buy
1,115,869
+485,347
+77% +$10.4M 0.08% 166
2022
Q1
$15.5M Sell
630,522
-13,700
-2% -$309K 0.04% 215
2021
Q4
$17.6M Buy
644,222
+440,377
+216% +$15.4M 0.04% 210
2021
Q3
$8.73M Buy
+203,845
New +$9.05M 0.02% 240

Other funds holding DH

Kayne Anderson Rudnick Investment Management's DH Position: Q2 2023 in Review

Kayne Anderson Rudnick Investment Management sold out of Definitive Healthcare (DH) in Q2 2023, closing a stake of 974,434 shares — an estimated $10.1M sold.

Kayne Anderson Rudnick Investment Management first reported a position in DH in Q3 2021 and held it in 7 quarters. The position peaked at $25.6M in Q2 2022. 137 funds tracked by Wall St. Rank hold DH as of Q2 2023.

  • Kayne Anderson Rudnick Investment Management reported no remaining Definitive Healthcare position as of Q2 2023 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 974,434 Definitive Healthcare shares in Q2 2023, an estimated $10.1M.
  • Kayne Anderson Rudnick Investment Management first reported a position in Definitive Healthcare in Q3 2021 and held it in 7 quarters.
  • Kayne Anderson Rudnick Investment Management's Definitive Healthcare position peaked at $25.6M in Q2 2022.
  • 137 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2023.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2023, filed 11 Aug 2023.